Advanced endothelial dysfunction in patients with coexistence of coronary artery disease and peripheral arterial disease - effects of Cilostazol on endothelial dysfunction in peripheral arterial disease
Not Applicable
- Conditions
- The cases with coexistence of coronary artery disease and peripheral arterial disease
- Registration Number
- JPRN-UMIN000010106
- Lead Sponsor
- Department of Cardiovascular Medicine, Faculty of Sciences, Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
(1)heart failure with reduced left ventricular systolic function (ejection fraction<50%) (2)severe valvular heart disease(3)cardiomyopathy (4)systemic illness [including advanced endocrine, hepatic, or renal diseases (5)active inflammatory diseases (6)cancer (7)with residual hemiplegia
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method endothelial evaluation of function by reactive hyperemia peripheral arterial tonometry
- Secondary Outcome Measures
Name Time Method The effect of Cilostazol to the peripheral artery disease patients